REVIEW PAPER
Effect of platelet-rich plasma in treating musculoskeletal disorders in athletes
1
Department of Biological, Chemical and Pharmaceutical Sciences and Technologies, University of Palermo, Palermo, Italy
2
Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (Promise), University of Palermo, Palermo, Italy
These authors had equal contribution to this work
Submission date: 2024-09-12
Acceptance date: 2024-11-24
Online publication date: 2025-03-19
Corresponding author
Laura Tomasello
Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (Promise), University of Palermo, Piazza delle Cliniche, 2, 90127, Palermo, Italy
Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (Promise), University of Palermo, Piazza delle Cliniche, 2, 90127, Palermo, Italy
KEYWORDS
TOPICS
ABSTRACT
Platelet-rich plasma (PRP) is a product of significant interest in the field of regenerative medicine due to its healing, immunomodulatory and anti-inflammatory properties. Although its role remains debated, PRP has undeniably shown considerable potential in aiding the healing of various injuries and pathologies across multiple fields, from dermatology (e.g., hair loss, skin scars) to reproductive medicine and inflammatory diseases (e.g., osteoarthritis). The aim of this review is to summarise and describe the role of PRP in treating common musculoskeletal injuries and pathologies in athletes. This population is at higher risk for such conditions due to the physical activities they perform. However, the application of PRP in this context has not been sufficiently explored in the literature. After providing a brief overview of precision and regenerative medicine – distinct yet interconnected fields – we will examine the key characteristics of PRP and its role in treating various musculoskeletal injuries in athletes. This review highlights the current applications of PRP, its potential for future use and its limitations.
REFERENCES (74)
1.
National Research Council (US) Committee on A Framework for Developing a New Taxonomy of Disease. Toward Precision Medicine: Building a Knowledge Network for Biomedical Research and a New Taxonomy of Disease. The National Academies Collection: Reports funded by National Institutes of Health. Washington (DC): National Academies Press (US); 2011, pp. 1–128; doi: 10.17226/ 13284.
2.
Montine TJ, Montine KS. Precision medicine: clarity for the clinical and biological complexity of Alzheimer’s and Parkinson’s diseases. J Exp Med. 2015;212(5):601–5; doi: 10.1084/JEM.201 50656.
3.
Marras C, Fereshtehnejad S-M, Berg D, Bohnen NI, Dujardin K, Erro R, Espay AJ, Halliday G, Van Hilten JJ, Hu MT, Jeon B, Klein C, Leentjens AFG, Mollenhauer B, Postuma RB, Rodríguez- Violante M, Simuni T, Weintraub D, Lawton M, Mestre TA. Transitioning from Subtyping to precision medicine in Parkinson’s disease: a purpose- driven approach. Mov Disord. 2024;39(3): 462–71; doi: 10.1002/MDS.29708.
4.
Tsimberidou AM, Fountzilas E, Nikanjam M, Kurzrock R. Review of precision cancer medicine: Evolution of the treatment paradigm. Cancer Treat Rev. 2020;86:102019; doi: 10.1016/J.CTRV.2020. 102019.
5.
Tobias DK, Merino J, Ahmad A, Aiken C, Benham JL, Bodhini D, et al. Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine. Nat Med. 2023;29(10):2438–57; doi: 10.1038/S4 1591-023-02502-5.
6.
Fang J, Wang X, Jiang W, Zhu Y, Hu Y, Zhao Y, Song X, Zhao J, Zhang W, Peng J, Wang Y. Platelet- rich plasma therapy in the treatment of diseases associated with orthopedic injuries. Tissue Eng Part B Rev. 2020;26(6):571–85; doi: 10.1089/ TEN.TEB.2019.0292.
7.
Emer J. Platelet-rich plasma (PRP): current applications in dermatology. Skin Therapy Lett. 2019; 5(24):1–6.
8.
Marx RE. Platelet-rich plasma (PRP): what is PRP and what is not PRP?. Implant Dent. 2001;10(4): 225–8; doi: 10.1097/00008505-200110000-00 002.
9.
Croisé B, Paré A, Joly A, Louisy A, Laure B, Goga D. Optimised centrifugation preparation of the platelet rich plasma: literature review. J Stomatol Oral Maxillofac Surg. 2020;121(2):150–4; doi: 10.1016/ J.JOR MAS.2019.07.001.
10.
Xu J, Gou L, Zhang P, Li H, Qiu S. Platelet-rich plasma and regenerative dentistry. Aust Dent J. 2020;65(2):131–42; doi: 10.1111/ADJ.12754.
11.
Giusti I, D’Ascenzo S, MacChiarelli G, Dolo V. In vitro evidence supporting applications of platelet derivatives in regenerative medicine. Blood Transfus. 2020;18(2):117–29; doi: 10.2450/2019.0164-19.
12.
Everts PA. Autologous Platelet-Rich Plasma and Mesenchymal Stem Cells for the Treatment of Chronic Wounds. Wound Healing – Current Perspectives; Nov. 2018; doi: 10.5772/INTECHOPEN. 80502.
13.
Collins T, Alexander D, Barkatali B. Platelet-rich plasma: a narrative review. EFOR T Open Rev. 2021;6(4):225–35; doi: 10.1302/2058-5241.6.20 0017.
14.
Wang Z, Zhu P, Liao B, You H, Cai Y. Effects and action mechanisms of individual cytokines contained in PRP on osteoarthritis. J Orthop Surg Res. 2023;18(1); doi: 10.1186/S13018-023-04119-3.
15.
Chung JY-F, Chan MK-K, Li JS-F, Chan AS-W, Tang PC-T, Leung K-T, To K-F, Lan H-Y, Tang PM-K. TGF- signaling: from tissue fibrosis to tumor microenvironment. Int J Mol Sci. 2021;22(14): 7575; doi: 10.3390/IJMS22147575.
16.
Wang R, Xu B. TGF- 1-modified MSC-derived exosomal miR-135b attenuates cartilage injury via promoting M2 synovial macrophage polarisation by targeting MAPK6. Cell Tissue Res. 2021; 384(1):113–27; doi: 10.1007/S00441-020-03319-1.
17.
Harrison P; Subcommittee on Platelet Physiology. The use of platelets in regenerative medicine and proposal for a new classification system: guidance from the SSC of the ISTH. J Thromb Haemost. 2018;16(9):1895–1900; doi: 10.1111/JTH.14223.
18.
Harrison TE, Bowler J, Cheng CI, Reeves KD. Optimising platelet-rich plasma: spin time and sample source. Bioengineering. 2023;10(11):1270; doi: 10.3390/bioengineering10111270.
19.
Carvalho A, Filipa Ferreira A, Soares M, Santos S, Tomé P, Machado-Simões J, Pais AS, Sousa AP, Paiva A, Almeida-Santos T. Optimization of platelet- rich plasma preparation for regenerative medicine: comparison of different anticoagulants and resuspension media. Bioengineering. 2024;11(3): 209; doi: 10.3390/bioengineering11030209.
20.
Etulain J, Mena HA, Meiss RP, Frechtel G, Gutt S, Negrotto S, Schattner M. An optimised protocol for platelet-rich plasma preparation to improve its angiogenic and regenerative properties. Sci Rep. 2018;8(1):1513; doi: 10.1038/s41598-018-19419-6.
21.
Arita A, Tobita M. Adverse events related to platelet- rich plasma therapy and future issues to be resolved. Regen Ther. 2024;26:496; doi: 10.1016/J. RETH.2024.07.004.
22.
Akbarzadeh S, McKenzie MB, Rahman MM, Cleland H. Allogeneic platelet-rich plasma: is it safe and effective for wound repair?. Eur Surg Res. 2021;62(1):1–9; doi: 10.1159/000514223.
23.
Grassi A, Napoli F, Romandini I, Samuelsson K, Zaffagnini S, Candrian C, Filardo G. Is platelet-rich plasma (PRP) effective in the treatment of acute muscle injuries? a systematic review and meta analysis. Sports Med. 2018;48(4):971–89; doi: 10.1007/S40279-018-0860-1.
24.
Andia I, Maffulli N. New biotechnologies for musculoskeletal injuries. Surgeon. 2019;17(4):244–55; doi: 10.1016/J.SURGE.2018.08.004.
25.
Oloff LM, Wilhelm I, Vora NS. Orthobiologic use in sports injuries. Clin Podiatr Med Surg. 2023; 40(1):169–79; doi: 10.1016/J.CPM.2022.07.011.
26.
Silvers-Granelli HJ, Cohen M, Espregueira-Mendes J, Mandelbaum B. Hamstring muscle injury in the athlete: state of the art. J ISAKOS. 2021;6(3): 170–81; doi: 10.1136/JISAKOS-2017-000145.
27.
Pretorius J, Habash M, Ghobrial B, Alnajjar R, Ellanti P. Current status and advancements in platelet-rich plasma therapy. Cureus. 2023;15(10): e47176; doi: 10.7759/CUREUS.47176.
28.
Hamid MSA, Ali MRM, Yusof A, George J, Lee LPC. Platelet-rich plasma injections for the treatment of hamstring injuries: a randomised controlled trial. Am J Sports Med. 2014;42(10): 2410–8; doi: 10.1177/0363546514541540.
29.
Heifner JJ, Kilgore 3rd JE, Nichols JA, Reb CW. Syndesmosis injury contributes a large negative effect on clinical outcomes: a systematic review. Foot Ankle Spec. 2024;17(3):284–94; doi: 10.1177/ 19386400211067865.
30.
Laver L, Carmont MR, McConkey MO, Palmanovich E, Yaacobi E, Mann G, Nyska M, Kots E, Mei- Dan O. Plasma rich in growth factors (PRGF) as a treatment for high ankle sprain in elite athletes: a randomised control trial. Knee Surg Sports Traumatol Arthrosc. 2015;23(11):3383–92; doi: 10. 1007/S00167-014-3119-X/TABLES/4.
31.
Samra DJ, Sman AD, Rae K, Linklater J, Refshauge KM, Hiller CE. Effectiveness of a single platelet-rich plasma injection to promote recovery in rugby players with ankle syndesmosis injury. BMJ Open Sport Exerc Med. 2015;1(1):000033; doi: 10.1136/BMJSEM-2015-000033.
32.
Hamilton B, Tol JL, Almusa E, Boukarroum S, Eirale C, Farooq A, Whiteley R, Chalabi H. Platelet- rich plasma does not enhance return to play in hamstring injuries: a randomised controlled trial. Br J Sports Med. 2015;49(14):943–50; doi: 10.1136/BJSPORTS-2015-094603.
33.
Reurink G, Goudswaard GJ, Moen MH, Weir A, Verhaar JAN, Bierma-Zeinstra SMA, Maas M, Tol JL; Dutch Hamstring Injection Therapy (HIT) Study Investigators. Platelet-rich plasma injections in acute muscle injury. N Engl J Med. 2014; 370(26):2546–7; doi: 10.1056/NEJMC1402340.
34.
Trunz LM, Landy JE, Dodson CC, Cohen SB, Zoga AC, Roedl JB. Effectiveness of hematoma aspiration and platelet-rich plasma muscle injections for the treatment of hamstring strains in athletes. Med Sci Sports Exerc. 2022;54(1):12–7; doi: 10.1249/ MSS.0000000000002758.
35.
Matthews W, Ellis R, Furness JW, Rathbone E, Hing W. Staging Achilles tendinopathy using ultrasound imaging: the development and investigation of a new ultrasound imaging criteria based on the continuum model of tendon pathology. BMJ Open Sport Exerc Med. 6(1):e000699; doi: 10.1136/BMJSEM-2019-000699.
36.
Dan M, Parr W, Broe D, Cross M, Walsh WR. Biomechanics of the knee extensor mechanism and its relationship to patella tendinopathy: a review. J Orthop Res. 2018;36(12):3105–12; doi: 10.1002/ JOR .24120.
37.
Filardo G, Kon E, Di Matteo B, Di Martino A, Tesei G, Pelotti P, Cenacchi A, Marcacci M. Platelet- rich plasma injections for the treatment of refractory Achilles tendinopathy: results at 4 years. Blood Transfus. 2014;12(4):533; doi: 10.2450/ 2014.0289-13.
38.
Charousset C, Zaoui A, Bellaiche L, Bouyer B. Are multiple platelet-rich plasma injections useful for treatment of chronic patellar tendinopathy in athletes? A prospective study. Am J Sports Med. 2014; 42(4):906–11; doi: 10.1177/0363546513519964.
39.
Dragoo JL, Wasterlain AS, Braun HJ, Nead KT. Platelet-rich plasma as a treatment for patellar tendinopathy: a double-blind, randomised controlled trial. Am J Sports Med. 2014;42(3):610– 8; doi: 10.1177/0363546513518416.
40.
Crescibene A, Napolitano M, Sbano R, Costabile E, AlmollaH. Infiltration of autologous growth factors in chronic tendinopathies. J Blood Transfus. 2015;2015:924380; doi: 10.1155/2015/924380.
41.
Guelfi M, Pantalone A, Vanni D, Abate M, Guelfi MGB, Salini V. Long-term beneficial effects of platelet-rich plasma for non-insertional Achilles tendinopathy. Foot Ankle Surg. 2015;21(3):178– 81; doi: 10.1016/J.FAS.2014.11.005.
42.
Scott A, LaPrade RF, Harmon KG, Filardo G, Kon E, Della Villa S, Bahr R, Moksnes H, Torgalsen T, Lee J, Dragoo JL, Engebretsen L. Platelet-rich plasma for patellar tendinopathy: a randomised controlled trial of leukocyte-rich PRP or leukocytepoor PRP versus saline. Am J Sports Med. 2019; 47(7):1654–61; doi: 10.1177/0363546519837954.
43.
Abate M, Di Carlo L, Belluati A, Salini V. Factors associated with positive outcomes of platelet-rich plasma therapy in Achilles tendinopathy. Eur J Orthop Surg Traumatol. 2020;30(5):859–67; doi: 10.1007/S00590-020-02642-1.
44.
Rodas G, Soler-Rich R, Rius-Tarruella J, Alomar X, Balius R, Orozco L, Masci L, Maffulli N. Effect of autologous expanded bone marrow mesenchymal stem cells or leukocyte-poor platelet-rich plasma in chronic patellar tendinopathy (with gap > 3 mm): preliminary outcomes after 6 months of a double-blind, randomised, prospective study. Am J Sports Med. 2021;49(6):1492–504; doi: 10.1177/0363546521998725.
45.
Rodas G. Soler R, Balius R, Alomar X, Peirau X, Alberca M, Sánchez A, Sancho JG, Rodellar C, Romero A, Masci L, Orozco L, Maffulli N. Autologous bone marrow expanded mesenchymal stem cells in patellar tendinopathy: protocol for a phase I/II, single-centre, randomised with active control PRP, double-blinded clinical trial. J Orthop Surg Res. 2019;14(1):441; doi: 10.1186/S13018-019- 1477-2.
46.
Hernández-Sánchez S, Poveda-Pagán EJ, Alakhdar- Mohmara Y, Hidalgo MD, Fernández-De-Las- Peñas C, Arias-Buría JL. Cross-cultural adaptation of the Victorian Institute of Sport Assessment- Achilles (VISA-A) Questionnaire for Spanish athletes with achilles tendinopathy. J Orthop Sports Phys Ther. 2018;48(2):111–20; doi: 10.2519/JOSPT. 2018.7402.
47.
Palazón-Bru A, Tomás Rodríguez MI, Mares- García E, Hernández-Sánchez S, Carbonell-Torregrosa MÁ, Gil-Guillén VF. The Victorian Institute of Sport Assessment Scale for Patellar Tendinopathy (VISA-P): a reliability generalisation metaanalysis. Clin J Sport Med. 2021;31(5):455–64; doi: 10.1097/JSM.0000000000000810.
48.
Korakakis V, Kotsifaki A, Stefanakis M, Sotiralis Y, Whiteley R, Thorborg K. Evaluating lower limb tendinopathy with Victorian Institute of Sport Assessment (VISA) questionnaires: a systematic review shows very-low-quality evidence for their content and structural validity – part I. Knee Surg Sports Traumatol Arthrosc. 2021;29(9):2749–64; doi: 10.1007/S00167-021-06598-5.
49.
Cacchio A, De Paulis F, Maffulli N. Development and validation of a new visa questionnaire (VISA-H) for patients with proximal hamstring tendinopathy. Br J Sports Med. 2014;48(6):448–52; doi: 10.1136/BJSPORTS-2012-091552.
50.
Ng A, Cavaliere R, Molchan L. Biologics in the treatment of plantar fasciitis. Clin Podiatr Med Surg. 2021;38(2):245–59; doi: 10.1016/J.CPM.2020.12. 009.
51.
Martinelli N, Marinozzi A, Carnì S, Trovato U, Bianchi A, Denaro V. Platelet-rich plasma injections for chronic plantar fasciitis. Int Orthop. 2013; 37(5):839–42; doi: 10.1007/s00264-012-1741-0.
52.
O’Malley MJ, Vosseller JT, Gu Y. Successful use of platelet-rich plasma for chronic plantar fasciitis. HSS J. 2013;9(2):129–33; doi: 10.1007/s11420- 012-9321-9.
53.
Wilson JJ, Lee KS, Miller AT, Wang S. Plateletrich plasma for the treatment of chronic plantar fasciopathy in adults: a case series. Foot Ankle Spec. 2014;7(1):61–7; doi: 10.1177/19386400135 09671.
54.
Gogna P, Gaba S, Mukhopadhyay R, Gupta R, Rohilla R, Yadav L. Plantar fasciitis: a randomised comparative study of platelet rich plasma and low dose radiation in sportspersons. Foot. 2016;28: 16–9; doi: 10.1016/J.FOO T.2016.08.002.
55.
Poenaru D, Badoiu S, Ionescu A. Therapeutic considerations for patients with chronic plantar fasciitis (review). Med Int. 2021;1(4):9; doi: 10.3892/ MI.2021.9.
56.
Berrigan W, Tao F, Kopcow J, Park AL, Allen I, Tahir P, Reddy A, Bailowitz Z. The effect of platelet dose on outcomes after platelet rich plasma injections for musculoskeletal conditions: a systematic review and meta-analysis. Curr Rev Musculoskelet Med. 2024;17(12):570–88; doi: 10.1007/S12178- 024-09922-X.
57.
Alessio-Mazzola M, Stambazzi C, Ursino C, Tagliafico A, Trentini R, Formica M. Ultrasound-guided autologous platelet-rich plasma injections versus focal ultrasound-guided extracorporeal shockwave therapy for plantar fasciitis in athletes and nonathletes: a retrospective comparative study with minimum 2-year follow-up. J Foot Ankle Surg. 2023;62(3):417–21; doi: 10.1053/J.JFAS.2022.10. 005.
58.
Tooth C, Goff lot A, Schwartz C, Croisier J-L, Beaudart C, Bruyère O, Forthomme B. Risk factors of overuse shoulder injuries in overhead athletes: a systematic review. Sports Health. 2020; 12(5):478–87; doi: 10.1177/1941738120931764.
59.
Steele MC, Lavorgna TR, Ierulli VK, Mulcahey, MK. Risk factors for shoulder injuries in female athletes playing overhead sports: a systematic review. Sports Health. 2024:19417381241259987, doi: 10.1177/19417381241259987.
60.
Hoffman JK, Protzman NM, Malhotra AD. Biologic augmentation of the ulnar collateral ligament in the elbow of a professional baseball pitcher. Case Rep Orthop. 2015;2015:130156; doi: 10.1155/ 2015/130157.
61.
Dines JS, Williams PN, ElAttrache N, Conte S, Tomczyk T, Osbahr DC, Dines DM, Bradley J, Ahmad CS. Platelet-rich plasma can be used to successfully treat elbow ulnar collateral ligament insufficiency in high-level throwers. Am J Orthop. 2016;45(5):296–300.
62.
Gordon AH, De Luigi A J. Adolescent pitcher recovery from partial ulnar collateral ligament tear after platelet-rich plasma. Curr Sports Med Rep. 2018;17(12):407–9; doi: 10.1249/JSR.00000000 00000549.
63.
Chauhan A, McQueen P, Chalmers PN, Ciccotti MG, Camp CL, D’Angelo J, Potter HG, Fealy SA, Erickson BJ, Hoenecke HR, Keefe D, McCauley J, Fronek J. Non-operative treatment of elbow ulnar collateral ligament injuries with and without platelet- rich plasma in professional baseball players: a comparative and matched cohort analysis. Am J Sports Med. 2019;47(13):3107–19; doi: 10.1177/ 0363546519876305.
64.
Thompson RG, Bradley K, Lourie GM. Ulnar nerve dysfunction at the elbow after platelet-rich plasma treatment for partial ulnar collateral ligament injuries. JSES Rev Rep Tech. 2020;1(1):41–4; doi: 10.1016/j.xrrt.2020.11.006.
65.
Xu Y, Li T, Wang L, Yao L, Li J, TangX. Platelet-rich plasma has better results for long-term functional improvement and pain relief for lateral epicondylitis: a systematic review and meta-analysis of randomised controlled trials. Am J Sports Med. 2024; 52(10):2646–56; doi: 10.1177/03635465231213 087.
66.
Andia I, Maffulli N. Platelet-rich plasma for managing pain and inflammation in osteoarthritis. Nat Rev Rheumatol. 2013;9(12):721–30; doi: 10.1038/NRR HEUM.2013.141.
67.
Pogliacomi F, Visigalli A, Valenti PG, Pedrazzini A, Bernuzzi G, Concari G, Vaienti E, Ceccarelli F. Rectus femoris myotendinous lesion treated with PRP: a case report. Acta Biomed. 2019;90(Suppl 12): 178–83; doi: 10.23750/ABM.V90I12-S.8932.
68.
Lutz RH, King JE, Sell TC, Early CL, Nguyen EM. Platelet-rich plasma treatment of a quadriceps tendon tear in a collegiate basketball athlete. Curr Sports Med Rep. 2023;22(11):370–4; doi: 10.1249/ JSR.0000000000001115.
69.
de Aysa PN, Garðarsson JG, Al-Dolaymi A, Bordalo- Rodrigues M, Laupheimer M, Fermín TM. Leukocyte-rich platelet-rich plasma injection in an acute-on-chronic rectus femoris injury of a professional soccer player: a case report. J ISAKOS. 2024;9(6):100286; doi: 10.1016/j.jisako.2024.06. 005.
70.
Poursalehian M, Lotfi M, Zafarmandi S, Bahri RA, Halabchi F. Hamstring injury treatments and management in athletes: a systematic review of the current literature. JBJS Rev. 2023;11(11); doi: 10.2106/JBJS.RVW.23.00161.
71.
Sellami M, Ben Abderrahmen A, Dhahbi W, Hayes LD, Zouhal H. Hemoglobin, hematocrit and plasma volume variations following combined sprint and strength: effect of advanced age. Sci Sports. 2021;36(1):13–21; doi: 10.1016/J.SCISPO. 2019.10.012.
72.
Rhibi F. Dhahbi W, Jebabli N, Bideau B, Prioux J, Ben-Attia M, Ben Abderrahman A, Optimization of high-intensity-interval-training program intensity to improve aerobic performance in healthy active subjects. Med Sport. 2022;75(4):461–76; doi: 10.23736/S0025-7826.22.04092-3.
73.
Mao AS, Mooney DJ. Regenerative medicine: current therapies and future directions. Proc Natl Acad Sci U S A. 2015;112(47):14452–9; doi: 10.1073/ PNAS.1508520112.
74.
Lightner AL, Chan T. Precision regenerative medicine. Stem Cell Res Ther. 2021;12(1):1–3; doi: 10.1186/S13287-020-02092-W/METRICS.
Share
RELATED ARTICLE
| eISSN: | 1899-1955 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
